Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out

Researchers who focus on one specialty are more likely to rise through the academic ranks, even though wicked societal ...

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potentialUp to ...

Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer

Magnet Biomedicine, a leading induced-proximity biotech company advancing rational molecular glue discovery, today announced ...
Le Lézard

MDVIP Expands Its Footprint with Two New Primary Care Practices in the Capital Region

MDVIP is proud to announce two Capital District medical practices are joining its network, with Sanjay Taneja, MD, in ...

IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine(TM), Advancing their AI×Bio Factory Hub from Baltimore to Africa

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

2026 BizWomen Mentoring Monday & Reception

Join us for an energizing afternoon of speed mentoring designed to connect women across all stages of their professional ...

Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir(R) platform.

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...
Hoodline

South San Francisco Snags Billion-Dollar AI Drug Lab From Nvidia And Lilly

South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...
The Malaysian Reserve

IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine™, Advancing their AI×Bio Factory Hub from Baltimore to Africa

IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ ...
Business Facilities

North Carolina: Business Facilities’ 2025 State Of The Year

For 2025, this annual award from Business Facilities magazine recognizes North Carolina economic development .This economic ...
TMCnet

insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...